To investigate the correlation between RBMS1 expression and the clinicopathological characteristics of HCC patients, we divided 103 HCC patients into high- and low-expression groups on the basis of the median value of RBMS1 IHC staining. This evidence concerns the gene RBMS1 and hepatocellular carcinoma.